Nurses now have a wealth of new and updated resources to ensure their patients with prostate cancer can make the best treatment choices they can, thanks to the Prostate Cancer
Thanks to the Prostate Cancer Foundation (PCF), oncology nurses now have a wealth of new and updated resources to help their patients with prostate cancer—and their families–make the best treatment choices they can.
In an interview with Oncology Nursing News, Christine Jones, the PCF’s chief operating officer, went into greater detail about the new resources that were released earlier this month, and explained how nurses can share them with their patients.
First, a newly updated 2019 Prostate Cancer Patient Guide ensures that the latest information makes its way to the hands of patients, doctors, nurses, and families in a timely manner. Written in easy-to-understand language and updated twice a year, this guide is an ideal resource for nurses to share with patients, said Jones.
“Most doctors and nurses believe a well-informed patient is a good patient and it makes the process of treatment better for all,” she said. “We can provide free printed copies of the patient guide to any medical offices that request them. This makes it easy for nurses to provide the guides to patients and provides a solid basis from which patients can formulate questions about their care.”
She also noted that after patients have read through different sections of the guide—such as those that deal with genetic testing and nutrition during treatment–nurses can help counsel their patients on how to access more information and make the most of the guide.
“While the guide is intended to be a comprehensive resource, we want it to contain a manageable amount of information,” said Jones. “Nurses can assist in following up on additional topics mentioned in the guide that are of interest to individual patients and their unique clinical circumstances, such as specific side effects, availability of molecular imaging, screening, and more.”
In addition to the updated Patient Guide, the PCF also announced:
Jones concluded by noting that these resources are not just helpful, but that they are backed by science, too. “The guides are fully reviewed and vetted by practicing specialists, including a urologist, medical oncologist, radiation oncologist, and cancer researchers.”
The Prostate Cancer Foundation is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $790 million and provided funding to more than 2,200 research programs at more than 220 cancer centers and universities. The PCF global research enterprise now extends to 22 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.
Key Advances in Cancer Survivorship Toxicity Management
July 15th 2022In this episode of The Vitals, Lidia Schapira, MD, FASCO, recounts highlights from the 2022 ASCO Symptoms and Survivorship track and underscores key takeaways for practitioners seeking to enhance the delivery of cancer survivorship care.
Enfortumab Vedotin Plus Pembrolizumab Improves Outcomes vs Chemo in Urothelial Cancer
April 20th 2024Patients with locally advanced or metastatic urothelial cancer treated with enfortumab vedotin plus pembrolizumab experienced a reduction in the risk for disease progression or death vs chemotherapy.